As of 2025, Ono Pharmaceutical has disclosed 3 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 3 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Ono Pharmaceutical's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13) | Metric Tonnes of CO2 equivalent (mtCO2e) | -30%a | 2030 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -100%a | 2035 |
Absolute-based Target* | Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13) | Metric Tonnes of CO2 equivalent (mtCO2e) | -60%a | 2050 |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
As of 2025, Ono Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a
As of 2025, Ono Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a
Ono Pharmaceutical's most ambitious operational target is to reduce these emissions by 100% by 2035, compared to a baseline of 29,800 Metric Tonnes of CO2 equivalent (mtCO2e) in 2017.a
As of 2024, Ono Pharmaceutical is ahead of schedule on its operational emissions reduction target, having achieved 70.13% of the planned reduction.a
As of 2025, Ono Pharmaceutical has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 4 out of the 15 Scope 3 categories defined by the GHG Protocol.a
Ono Pharmaceutical's most ambitious value chain target is to reduce these emissions by 60% by 2050, compared to a baseline of 123,100 Metric Tonnes of CO2 equivalent (mtCO2e) in 2017.a
As of 2024, Ono Pharmaceutical is ahead of schedule on its value chain emissions reduction target, having achieved 30.6% of the planned reduction.a